20.01
+0(+0.00%)
Currency In USD
Address
10931 North Torrey Pines Road
La Jolla, CA 92037
United States of America
Phone
858 333 7830
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
255
First IPO Date
May 27, 2021
| Name | Title | Pay | Year Born |
| Andrew Spaventa | Founder, Chief Executive Officer, President & Chairperson of the Board | 853,558 | 1986 |
| David L. Barker | Founder, Member of Scientific Advisory Board & Independent Director | 66,250 | 1942 |
| Dalen Meeter | Chief Financial Officer | 545,675 | 1979 |
| Eli N. Glezer | Founder, Chief Scientific Officer & Chair of Scientific Advisory Board | 548,317 | 1970 |
| Jyotsna Ghai | Chief Operating Officer | 0 | 1959 |
| Eric Stier | Senior Vice President, General Counsel & Secretary | 0 | 1976 |
| Jeff Bullard | Head of Sales | 0 | N/A |
| Jorge Velarde Jr. | Chief Business Officer | 0 | 1967 |
| Vincent Brancaccio | Head of Human Resources | 0 | 1983 |
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.